
Defence Successfully Closes Second Tranche of Fully Subscribed Financing, Raising $4.2 Million
Breaking News: Defence Therapeutics Inc. Announces Successful Completion of Private Placement Montreal, Quebec–(Newsfile Corp. – January 31, 2025) Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), a leading Canadian biopharmaceutical company, has just announced the successful closing of the 2nd tranche of its non-brokered private placement. The company raised an impressive $3,915,000 through the…